Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (ANIK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ANIK · as of Jun 8, 2026
Key Statistics
Explore Anika Therapeutics, Inc. Data
anik stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
Competitors & Peers
anik competitorsANIK
ANIX
APYX
ARAY
AVR
LNSRStock Performance
Full HistoryAbout Anika Therapeutics, Inc.
Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core …
what is anika therapeutics, inc. · anik stock overview · anika therapeutics, inc. company profile · who is anika therapeutics, inc. ceo · anik NASDAQ · anika therapeutics, inc. headquarters · anika therapeutics, inc. business segments
About Stock Overview & Key Data
Anika Therapeutics, Inc. (ANIK) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since May 3, 1993. As of the latest trading session, ANIK stock price is $14.60, with a market capitalization of $194.3M. The stock has returned +26.74% over the past 12 months and +51.93% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Anika Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Anika Therapeutics, Inc. reported revenue of $112.8M and net income of -$10.9M. For detailed data — including Anika Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Anika Therapeutics, Inc. (ANIK) stock price is $14.60. The stock is traded on NASDAQ under the ticker symbol ANIK. The 52-week range is $7.87 – $16.24.